There are numerous risks for President Trump's agenda now that the GOP health-care bill is dead, analysts say. » Read More
The Justice Department and FBI actions ahead of 2016 election is to be reviewed, inspector general says. CNBC's Eamon Javers reports.
Rep. Devin Nunes (R-Calif.) weighs in on the GOP's proposed tax plan.
One market technician sees stocks heading higher even if the Trump rally has lost a bit of steam.
Matthew Niknam, Deutsche Bank director of equity research, discusses the firm's downgrade of AT&T to "hold" and the potential deal between the telecom giant and Time Warner.
Trump is calling the allegations about Russian-information gathering on him "fake news" and one former CIA analyst is backing him up.
Discussing what CEOs expect from the U.S. economy under President-elect Trump with YPO members Dan Levin, Cain Millwork CEO, and Philip Koosed, Bamko founder & CEO.
CNBC's Robert Frank reports the latest on Trump's plans to break some ties with his businesses.
CNBC's Steve Liesman and David Smick, author of "The Great Equalizer," discuss President-elect Trump's economic agenda.
CNBC's Sue Herera reports on the response from the pharmaceutical lobby following President-elect Donald Trump's comments on the industry.
Michael King, JMP Securities senior analyst, weighs in on the biotech sector as President-elect Donald Trump puts the pharmaceutical industry in his cross hairs, calling it "disastrous."
Chris Retzler, Needham Small Cap Growth Fund, and Peter Andersen, Fiduciary Trust CIO, weigh in on the markets in light of President-elect Donald Trump's first news conference since Election Day.
Volkswagen pleads guilty in its emissions scandal to conspiracy and obstructing justice. The company will pay $4.3 billion in fines. CNBC's Susan Li reports.
CNBC's Eamon Javers reports the latest on the Senate Foreign Relations Committee confirmation hearing for Rex Tillerson to be secretary of State.
After Donald Trump mentions Lockheed Martin in his news conference, the company tells CNBC it understands his "concerns" with F35 program, and is committed to drive down cost. CNBC's Morgan Brennan reports.
Tom Donohue, CEO of the United States Chamber of Commerce, weighs in on President-elect Donald Trump's drug pricing and infrastructure plans.
Tom Donohue, CEO of the United States Chamber of Commerce, weighs in on President-elect Donald Trump's first news conference since Election Day.
George David Banks, American Council for Capital Formation vice president, and CNBC Contributors Sara Fagen and Jared Bernstein weigh in on President-elect Donald Trump's first news conference since Election Day.
CNBC's Bob Pisani takes a closer look at how the market's reaction to President-elect Donald Trump's first news conference since Election Day.
CNBC's John Harwood reports on President-elect Donald Trump's first news conference since Election Day.
The key level Gross wrote about Tuesday is not the one investors should be watching, two traders said.